The efficacy of DUPIXENT has been studied in 3 clinical trials with approximately 2,100 adults with uncontrolled moderate‑to‑severe eczema.

• DUPIXENT was evaluated in these studies when taken alone and when taken with topical corticosteroids.

The efficacy of DUPIXENT has been studied in a 16-week clinical trial with 251 teens ages 12-17 years with uncontrolled moderate‑to‑severe eczema.

The efficacy of DUPIXENT has been studied in a 16-week clinical trial with 367 children ages 6-11 years with uncontrolled severe eczema also taking topical corticosteroids.

The efficacy of DUPIXENT has been studied in a 16-week clinical trial with 162 children ages 6 months-5 years with uncontrolled moderate‑to‑severe eczema also taking topical corticosteroids.

Patients enrolled in these studies were not well controlled with prescription therapies used on the skin (topical), or could not use topical therapies.